Danaher Corporation (NYSE:DHR) Shares Sold by TD Private Client Wealth LLC

TD Private Client Wealth LLC cut its position in Danaher Corporation (NYSE:DHR - Free Report) by 15.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,847 shares of the conglomerate's stock after selling 2,611 shares during the quarter. TD Private Client Wealth LLC's holdings in Danaher were worth $2,839,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter valued at about $27,000. GHP Investment Advisors Inc. boosted its position in shares of Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the period. Sierra Ocean LLC boosted its position in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after purchasing an additional 76 shares during the period. Hurley Capital LLC acquired a new stake in shares of Danaher in the 4th quarter valued at about $34,000. Finally, Rialto Wealth Management LLC acquired a new stake in shares of Danaher in the 4th quarter valued at about $34,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Price Performance

NYSE DHR traded up $1.07 during mid-day trading on Tuesday, hitting $200.70. The stock had a trading volume of 4,225,555 shares, compared to its average volume of 4,245,021. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a market cap of $143.63 billion, a price-to-earnings ratio of 38.97, a P/E/G ratio of 2.85 and a beta of 0.77. The company has a 50 day simple moving average of $195.71 and a 200 day simple moving average of $206.90. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.80% and a net margin of 15.81%. The firm had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.64%. Danaher's payout ratio is currently 24.85%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on DHR shares. Leerink Partners increased their price objective on Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 23rd. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research report on Friday, March 14th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Bank of America decreased their price objective on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Finally, Jefferies Financial Group decreased their price objective on Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $248.00.

Insider Buying and Selling at Danaher

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares of the company's stock, valued at approximately $3,005,442. This trade represents a 51.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. Company insiders own 11.20% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.